SEC Form 4 · accession 0001683168-16-000850
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Allen Northey
Officer — Exec. VP of Res & Devlpment
Period of report
Nov 30, 2016
Accepted (ET)
Dec 2, 2016 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | Nov 30, 2016 | A | 4,678 | $4.81 | A | 4,678 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were granted to Mr. Northey as bonus compensation, based on the closing price of the Corporation's common stock of $4.81 on November 30, 2016.